Pendapatan dodolan perusahaan assemblybio.com (ASMB)

Assembly Biosciences develops advanced antiviral agents for the cellular eradication of hepatitis B. Business revenues rely on the commercialization of next-generation therapies. Financial stability is supported by milestone payments from global partners. The company's gross sales level reflects demand dynamics, where the current mark equals 0.07, serving as an indicator of the assets' fundamental condition.

Assembly Biosciences (ASMB): Pendapatan perusahaan saka 04.07.2022 nganti 13.11.2026

Rincian metrik komprehensif lan analitis Assembly Biosciences, Inc. (ASMB)

- rega pasar lan target rega analis:

Rega bursa Assembly Corp|ASMB - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar Assembly Biosciences, Inc.|ASMB - Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham Assembly Biosciences|ASMB - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku assemblybio.com|ASMB - Aset Agregat Perusahaan

- informasi babagan utang lan solvabilitas:

Koefisien Total Utang marang Modal Assembly Biosciences|ASMB - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Assembly Bio|ASMB - Utang perusahaan|Utang marang nilai buku Assembly Biosciences, Inc.|ASMB - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Assembly Biosciences|Likuiditas cepet assemblybio.com

- data bathi resik lan rasio valuasi:

ASMB - Penghasilan resik|Bathi resik sing dikarepake Assembly Biosciences|ASMB - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi assemblybio.com|ASMB - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Assembly Biosciences, Inc.|ASMB - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Assembly Biosciences|ASMB - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan assemblybio.com|ASMB - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Assembly Biosciences

- indikator volume dodolan lan pendapatan:

ASMB - Pendapatan lan volume dodolan|Volume dodolan mangsa ngarep perusahaan Assembly Corp|ASMB - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Assembly Biosciences, Inc.

Analisis komprehensif perusahaan:ASMB Assembly Corp

Produk asil prodhuksi Assembly Biosciences

This metric captures the aggregate cash flow from product sales, reflecting actual market demand for goods. Rising values confirm business expansion, while stagnation signals distribution challenges. By analyzing the commercial sales figures of the company, an investor can promptly diagnose deviations from the business plan. For Assembly Biosciences (ASMB), this metric is critical due to the fierce competition with pharma behemoths in the hepatitis B therapy segment. Success in this scientific race directly determines the financial stability of the issuer.

Pesaing wigati

Total pendapatan perusahaan Arrowhead Corp ARWR|Pendapatan perusahaan Mirum Pharmaceuticals (MIRM)|DVAX (Dynavax Technologies Corporation) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan ABUS (Arbutus Biopharma Corporation)|Pendapatan lan volume dodolan Inventiva SA IVA|GYRE - Pendapatan perusahaan|Pendapatan reged perusahaan Galectin Therapeutics GALT|genfit.com (GNFT) - Pendapatan perusahaan|DRRX - Pendapatan reged perusahaan|ALGS (Aligos Therapeutics Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan BioVie Pharma BIVI|Pendapatan perusahaan Galmed Pharmaceuticals (GLMD)|Dodolan perusahaan ENDRA Corp NDRA|Pendapatan lan volume dodolan HEPA (Hepion Pharmaceuticals, Inc.)